169 related articles for article (PubMed ID: 9116645)
1. Antigenic epitope mapping of the M24 protein of Streptococcus pyogenes: implications for serodiagnosis of rheumatic fever.
Norton RE; Heuzenroeder M; Manning PA
FEMS Immunol Med Microbiol; 1996 Dec; 16(3-4):267-71. PubMed ID: 9116645
[TBL] [Abstract][Full Text] [Related]
2. Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci.
Pruksakorn S; Currie B; Brandt E; Martin D; Galbraith A; Phornphutkul C; Hunsakunachai S; Manmontri A; Good MF
Lancet; 1994 Sep; 344(8923):639-42. PubMed ID: 7520963
[TBL] [Abstract][Full Text] [Related]
3. New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.
Brandt ER; Sriprakash KS; Hobb RI; Hayman WA; Zeng W; Batzloff MR; Jackson DC; Good MF
Nat Med; 2000 Apr; 6(4):455-9. PubMed ID: 10742155
[TBL] [Abstract][Full Text] [Related]
4. Antibody levels to the class I and II epitopes of the M protein and myosin are related to group A streptococcal exposure in endemic populations.
Brandt ER; Yarwood PJ; McMillan DJ; Vohra H; Currie B; Mammo L; Pruksakorn S; Saour J; Good MF
Int Immunol; 2001 Oct; 13(10):1335-43. PubMed ID: 11581178
[TBL] [Abstract][Full Text] [Related]
5. Mapping a conserved conformational epitope from the M protein of group A streptococci.
Relf WA; Cooper J; Brandt ER; Hayman WA; Anders RF; Pruksakorn S; Currie B; Saul A; Good MF
Pept Res; 1996; 9(1):12-20. PubMed ID: 8727479
[TBL] [Abstract][Full Text] [Related]
6. Can class I epitope of M protein be a diagnostic marker for rheumatic fever in populations endemic for group A streptococci?
Brandt ER; Currie B; Mammo L; Pruksakorn S; Good MF
Lancet; 1998 Jun; 351(9119):1860. PubMed ID: 9652675
[No Abstract] [Full Text] [Related]
7. Functional analysis of IgA antibodies specific for a conserved epitope within the M protein of group A streptococci from Australian Aboriginal endemic communities.
Brandt ER; Hayman WA; Currie B; Carapetis J; Jackson DC; Do KA; Good MF
Int Immunol; 1999 Apr; 11(4):569-76. PubMed ID: 10323210
[TBL] [Abstract][Full Text] [Related]
8. The future streptococcal M. vaccine against rheumatic fever.
Imran M; Jan A
J Pak Med Assoc; 1988 Jul; 38(7):176-7. PubMed ID: 3149682
[No Abstract] [Full Text] [Related]
9. Type-specific antibodies to structurally defined fragments of streptococcal M proteins in patients with acute rheumatic fever.
Bisno AL; Berrios X; Quesney F; Monroe DM; Dale JB; Beachey EH
Infect Immun; 1982 Nov; 38(2):573-9. PubMed ID: 6754620
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of group A streptococcal isolates from tropical Australia with high prevalence of rheumatic fever: probing for signature sequences to identify members of the family of serotype 5.
Hartas J; Goodfellow AM; Currie BJ; Sriprakash KS
Microb Pathog; 1995 May; 18(5):345-54. PubMed ID: 7476099
[TBL] [Abstract][Full Text] [Related]
11. Identification of T cell autoepitopes that cross-react with the C-terminal segment of the M protein of group A streptococci.
Pruksakorn S; Currie B; Brandt E; Phornphutkul C; Hunsakunachai S; Manmontri A; Robinson JH; Kehoe MA; Galbraith A; Good MF
Int Immunol; 1994 Aug; 6(8):1235-44. PubMed ID: 7981150
[TBL] [Abstract][Full Text] [Related]
12. Immunological crossreactivity between the class I epitope of streptococcal M protein and myosin.
Cunningham MW; Quinn A
Adv Exp Med Biol; 1997; 418():887-92. PubMed ID: 9331792
[No Abstract] [Full Text] [Related]
13. Pathogenesis of rheumatic fever: a review.
Rotta J
Ann Trop Paediatr; 1983 Mar; 3(1):1-8. PubMed ID: 6191642
[No Abstract] [Full Text] [Related]
14. Immune response against M protein-conserved region peptides from prevalent group A Streptococcus in a North Indian population.
Gupta VK; Sekhar S; Dhanda V; Toor D; Kumar R; Chakraborti A
J Microbiol Immunol Infect; 2016 Jun; 49(3):352-8. PubMed ID: 25087198
[TBL] [Abstract][Full Text] [Related]
15. Determination of group a streptococcal anti-M type-specific antibody in sera of rheumatic fever patients after 45 years.
Bencivenga JF; Johnson DR; Kaplan EL
Clin Infect Dis; 2009 Oct; 49(8):1237-9. PubMed ID: 19761409
[TBL] [Abstract][Full Text] [Related]
16. Type-specific antibodies to purified streptococcal M proteins from potentially rheumatogenic M-types in patients with rheumatic fever and rheumatic heart disease.
Thakur A; Singhal S; Prakash K
J Med Microbiol; 1996 Dec; 45(6):483-9. PubMed ID: 8958254
[TBL] [Abstract][Full Text] [Related]
17. Protective and nonprotective epitopes from amino termini of M proteins from Australian aboriginal isolates and reference strains of group A streptococci.
Brandt ER; Teh T; Relf WA; Hobb RI; Good MF
Infect Immun; 2000 Dec; 68(12):6587-94. PubMed ID: 11083769
[TBL] [Abstract][Full Text] [Related]
18. [Immunologic reactions with group-specific antigens of group A Streptococcus in rheumatic fever].
Zborovskiĭ AB; Lempert BA; Belousov SD; Filimonova IuK
Sov Med; 1990; (1):3-6. PubMed ID: 1693448
[TBL] [Abstract][Full Text] [Related]
19. Cutting edge issues in rheumatic fever.
Chang C
Clin Rev Allergy Immunol; 2012 Apr; 42(2):213-37. PubMed ID: 21597903
[TBL] [Abstract][Full Text] [Related]
20. Cross-reactivity between streptococcus and human tissue: a model of molecular mimicry and autoimmunity.
Froude J; Gibofsky A; Buskirk DR; Khanna A; Zabriskie JB
Curr Top Microbiol Immunol; 1989; 145():5-26. PubMed ID: 2680297
[No Abstract] [Full Text] [Related]
[Next] [New Search]
